SK
Sadananda Kumar Giliyaru
About Sadananda Kumar Giliyaru
Data last updated:
Sadananda Kumar Giliyaru is an Additional Director at Skizze Pharmaceuticals Private Limited (since 2023) and Director at Skintillio Healthcare Private Limited (since 2023). The companies operate in Pharma. The largest current company by reported revenue is Skizze Pharmaceuticals Private Limited at ₹1,729 (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 09 Sep 2023 | 2020 | ₹1,729 (FY 2025) | Active | |
| Director | 29 Nov 2023 | 2023 | Active |
Board colleagues of Sadananda Kumar Giliyaru
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kadegowda Somashekar | 08894166 | Skizze Pharmaceuticals Private Limited , Skintillio Healthcare Private Limited | Director |
| Narayana Gowda Thanuja Prasad | 02809392 | Skizze Pharmaceuticals Private Limited , Skintillio Healthcare Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sadananda Kumar Giliyaru
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sadananda Kumar Giliyaru
Sadananda Kumar Giliyaru currently holds 2 directorships: Skizze Pharmaceuticals Private Limited (Additional Director, since 09 Sep 2023, revenue ₹1,729 (FY 2025)); Skintillio Healthcare Private Limited (Director, since 29 Nov 2023).
Sadananda Kumar Giliyaru was first appointed on 09 Sep 2023 as Additional Director at Skizze Pharmaceuticals Private Limited.
The current boards of Sadananda Kumar Giliyaru's companies include Kadegowda Somashekar (Skizze Pharmaceuticals Private Limited), Narayana Gowda Thanuja Prasad (Skizze Pharmaceuticals Private Limited).